Overview

EZH


'EZH' can also refer to...

EZH

PRC2/EED-EZH complexes

PRC2/EED-EZH complexes

Targeting histone methyltransferase EZH2 as cancer treatment

TR-01Ezh2, A NOVEL TARGET IN TREATMENT OF MEDULLOBLASTOMA

MB-72THE ROLE OF EZH2 IN MEDULLOBLASTOMA

DISTINCT AND SEPARABLE ROLES FOR HISTONE METHYLTRANSFERASE EZH2 IN NEUROGENIC ASTROCYTES

NIPP1 maintains EZH2 phosphorylation and promoter occupancy at proliferation-related target genes

13PEXPRESSION OF IRAK-1 AND EZH-2 IN IMPRINTS OF NSCLC AND PRENEOPLASTIC LESIONS

An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients

EZH2 polymorphism and benefit from bevacizumab in colorectal cancer: another piece to the puzzle

Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells

Survival of skin cancer stem cells requires the Ezh2 polycomb group protein

PCAF-primed EZH2 acetylation regulates its stability and promotes lung adenocarcinoma progression

L07.04PRECLINICAL CHARACTERIZATION OF E7438, A POTENT, SELECTIVE EZH2 INHIBITOR WITH ROBUST ANTITUMOR ACTIVITY AGAINST EZH2 MUTATED NHL XENOGRAFTS IN MICE

The phosphatase interactor NIPP1 regulates the occupancy of the histone methyltransferase EZH2 at Polycomb targets

Cooperation between EZH2, NSPc1-mediated histone H2A ubiquitination and Dnmt1 in HOX gene silencing

3P17-Demethoxygeldanamycin inhibits self-renewal of breast cancer stem cells through EZH2/c-Myc/Bmi1 pathway

High protein expression of EZH2 is related to unfavorable outcome to tamoxifen in metastatic breast cancer

 

More Like This

Show all results sharing this subject:

  • Medicine and Health

GO

Show Summary Details

Quick Reference

Polycomb group (PcG) proteins (enhancer of zeste homologues) that are the catalytic component of the polycomb repressive complexes (PRC2/EED-EZH complexes), histone-lysine N-methyltransferases, EC 2.1.1.43). EZH2 (746 aa) is a marker for aggressiveness in prostate and breast carcinoma.

Subjects: Medicine and Health.


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.